Literature DB >> 9250439

Psychotic features and combat-associated PTSD.

M B Hamner1.   

Abstract

Psychotic symptoms and psychotic disorder diagnoses have occasionally been reported in association with chronic posttraumatic stress disorder (PTSD). Although psychotic features may be related to core PTSD symptoms, i.e., part of the reexperiencing phenomena, it is possible that they are secondary to certain comorbid disorders which are also prevalent in this patient population, e.g. major depression or substance abuse. In a prospective study, combat associated PTSD patients (n = 25) were administered clinical ratings, including the Structured Clinical Interview for DSM-III-R with psychotic screen (SCID-P), Clinician Administered PTSD Scale (CAPS) and the Impact of Events Scale (IES). Thirty-six percent (n = 9) endorsed psychotic symptoms with associated comorbidity including: major depressive episode, bipolar disorder, alcohol or polysubstance abuse panic disorder, and phobias. All but one of the patients with psychotic features also met criteria for major depressive episode. None had a primary psychotic disorder diagnosis. There were no significant differences in total CAPS scores between patients with or without psychotic features (82.6 +/-0 17.6 versus 75.3 +/- 22.4, p ns), nor for the different symptom cluster subscales. There were also no differences in the IES scores between groups (34.8 +/- 10 versus 32.6 +/- 10 p ns). This suggests that these psychotic features may not necessarily reflect severity of PTSD symptoms. PTSD may share a common diathesis with mood disorders including psychotic depression. Further study is needed of these phenomena.

Entities:  

Mesh:

Year:  1997        PMID: 9250439     DOI: 10.1002/(sici)1520-6394(1997)5:1<34::aid-da6>3.0.co;2-5

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  11 in total

Review 1.  The epidemiology of substance use disorders in US Veterans: A systematic review and analysis of assessment methods.

Authors:  Chiao-Wen Lan; David A Fiellin; Declan T Barry; Kendall J Bryant; Adam J Gordon; E Jennifer Edelman; Julie R Gaither; Stephen A Maisto; Brandon D L Marshall
Journal:  Am J Addict       Date:  2015-12-22

2.  Pharmacotherapy of treatment-resistant combat-related posttraumatic stress disorder with psychotic features.

Authors:  Nela Pivac; Dragica Kozarić-Kovacić
Journal:  Croat Med J       Date:  2006-06       Impact factor: 1.351

3.  Neuroleptic use in the treatment of Post-Traumatic Stress Disorder.

Authors:  M J Sernyak; T R Kosten; A Fontana; R Rosenheck
Journal:  Psychiatr Q       Date:  2001

4.  Evidence for a psychotic posttraumatic stress disorder subtype based on the National Comorbidity Survey.

Authors:  Mark Shevlin; Cherie Armour; Jamie Murphy; James E Houston; Gary Adamson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-09-02       Impact factor: 4.328

5.  Rate and predictors of psychotic symptoms after Kashmir earthquake.

Authors:  Muhammad Ayub; Khalid Saeed; David Kingdon; Farooq Naeem
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-11-25       Impact factor: 5.270

6.  Psychological consequences of war trauma and postwar social stressors in women in Bosnia and Herzegovina.

Authors:  Miro Klaric; Branka Klarić; Aleksandra Stevanović; Jasna Grković; Suzana Jonovska
Journal:  Croat Med J       Date:  2007-04       Impact factor: 1.351

7.  Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder.

Authors:  Nela Pivac; Dragica Kozaric-Kovacic; Dorotea Muck-Seler
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

8.  A diagnostic dilemma between psychosis and post-traumatic stress disorder: a case report and review of the literature.

Authors:  Ricardo Coentre; Paddy Power
Journal:  J Med Case Rep       Date:  2011-03-10

9.  Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder.

Authors:  Sriram Ramaswamy; David Driscoll; Lynette M Smith; Subhash C Bhatia; Frederick Petty
Journal:  Contemp Clin Trials Commun       Date:  2015-12-18

10.  Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder.

Authors:  Jeffrey L Berlant
Journal:  BMC Psychiatry       Date:  2004-08-18       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.